About NBR Polska
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Boehringer Ingelheim
4
Eli Lilly and Company
2
Anji Pharma
1
Aziende Chimiche Riunite Angelini Francesco S.p.A
1
Bayer
1
Kowa Research Institute, Inc.
1
Viela Bio (acquired by Horizon Therapeutics)
1
Clinical Trials at NBR Polska
During the past decade, NBR Polska conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 3 clinical trials were completed, i.e. on
average, 30% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 1 clinical trials were completed. i.e. 14.3%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Cardiovascular and Renal Microvascular Outcome Study With Linagliptin in Patients With Type 2 Diabetes Mellitus (CARMELINA)
2013-07-10
2018-01-18
Completed
6,991
Empagliflozin as Adjunctive to InSulin thErapy Over 52 Weeks in Patients With Type 1 Diabetes Mellitus (EASE-2)
2015-06-30
2017-10-23
Completed
730
Pemafibrate to Reduce Cardiovascular OutcoMes by Reducing Triglycerides IN patiENts With diabeTes (PROMINENT)
2017-03-23
2022-07-27
Terminated
10,544
A Study to Test Whether Different Doses of BI 456906 Are Effective in Treating Adults With Type 2 Diabetes.
2020-04-30
2021-11-04
Completed
413
A Study to Test the Effect of Different Doses of BI 685509 on Kidney Function in People With Diabetic Kidney Disease
2021-04-27
2022-12-27
Completed
243
Study of VIB7734 for the Treatment of Moderate to Severely Active SLE
2021-06-24
2023-07-01
Active, not recruiting
214
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "NBR Polska" #1 sponsor was "Boehringer Ingelheim" with 4 trials, followed by "Eli Lilly and Company" with 2 trials
sponsored, "Anji Pharma" with 1 trials sponsored, "Aziende Chimiche Riunite Angelini Francesco S.p.A" with 1 trials sponsored and "Bayer"
with 1 trials sponsored. Other sponsors include -3 different institutions and
companies that sponsored additional 7 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "NBR Polska"
#1 collaborator was "Eli Lilly and Company" with 2 trials as a collaborator, "Brigham and Women's Hospital" with 1 trials as a collaborator and "Chiltern International Inc." with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were
collaborators in the rest 3 trials.
Clinical Trials Conditions at NBR Polska
According to Clinical.Site data, the most researched conditions in "NBR Polska" are
"Diabetes Mellitus, Type 2" (3 trials), "Atrial Fibrillation" (1 trials), "Diabetes" (1 trials), "Diabetes Mellitus, Type 1" (1 trials) and "Diabetic Nephropathies" (1 trials). Many other conditions were trialed in "NBR Polska" in a lesser frequency.
Clinical Trials Intervention Types at NBR Polska
Most popular intervention types in "NBR Polska" are "Drug" (11 trials) and "Other" (2 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (8 trials), "Apixaban" (1 trials), "Apixaban matching placebo" (1 trials), "Asundexian (BAY2433334)" (1 trials) and "Asundexian matching placebo" (1 trials). Other intervention names were less common.
Clinical Trials Genders at NBR Polska
The vast majority of trials in "NBR Polska" are
11 trials for "All" genders.
Clinical Trials Status at NBR Polska
Currently, there are NaN active trials in "NBR Polska".
undefined are not yet recruiting,
2 are recruiting,
2 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 5 completed trials in NBR Polska,
1 suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in NBR Polska, 0 "Phase 1"
clinical trials were conducted, 4 "Phase 2" clinical
trials and 6 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 0 trials that are defined as “Not Applicable".